Shigella flexneri evades LPS ubiquitylation through IpaH1.4-mediated degradation of RNF213

Pathogens have evolved diverse strategies to counteract host immunity. Ubiquitylation of lipopolysaccharide (LPS) on cytosol-invading bacteria by the E3 ligase RNF213 creates 'eat me' signals for antibacterial autophagy, but whether and how cytosol-adapted bacteria avoid LPS ubiquitylation remains poorly understood. Here, we show that the enterobacterium Shigella flexneri actively antagonizes LPS ubiquitylation through IpaH1.4, a secreted effector protein with ubiquitin E3 ligase activity. IpaH1.4 binds to RNF213, ubiquitylates it and targets it for proteasomal degradation, thus counteracting host-protective LPS ubiquitylation. To understand how IpaH1.4 recognizes RNF213, we determined the cryogenic electron microscopy structure of the IpaH1.4-RNF213 complex. The specificity of the interaction is achieved through the leucine-rich repeat of IpaH1.4, which binds the RING domain of RNF213 by hijacking the conserved RING interface required for binding to ubiquitin-charged E2 enzymes. IpaH1.4 also targets other E3 ligases involved in inflammation and immunity through binding to the E2-interacting face of their RING domains, including the E3 ligase LUBAC that is required for the synthesis of M1-linked ubiquitin chains on cytosol-invading bacteria downstream of RNF213. We conclude that IpaH1.4 has evolved to antagonize multiple antibacterial and proinflammatory host E3 ligases.

Authors

Institutions

Publication Details

Journal
Nature Structural & Molecular Biology
Published
2025-04-09
DOI
https://doi.org/10.1038/s41594-025-01530-8
Citations
8
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
9.48

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Shigella flexneri evades LPS ubiquitylation through IpaH1.4-mediated degradation of RNF213

Felix Randow, Keith B. Boyle, Ana Crespillo-Casado, Elsje G. Otten et al.
8 citations
Nature Structural & Molecular Biology
Autophagy in Disease and Therapy
9.48
article

Shigella flexneri evades LPS ubiquitylation through IpaH1.4-mediated degradation of RNF213

Felix Randow, Keith B. Boyle, Ana Crespillo-Casado, Elsje G. Otten, Felix Scharte, Pierre‐Mehdi Hammoudi, Prathyush Pothukuchi, Claudio Pathe, Neal M. Alto, Katerina Naydenova
article en
8 citations

Abstract

Pathogens have evolved diverse strategies to counteract host immunity. Ubiquitylation of lipopolysaccharide (LPS) on cytosol-invading bacteria by the E3 ligase RNF213 creates 'eat me' signals for antibacterial autophagy, but whether and how cytosol-adapted bacteria avoid LPS ubiquitylation remains poorly understood. Here, we show that the enterobacterium Shigella flexneri actively antagonizes LPS ubiquitylation through IpaH1.4, a secreted effector protein with ubiquitin E3 ligase activity. IpaH1.4 binds to RNF213, ubiquitylates it and targets it for proteasomal degradation, thus counteracting host-protective LPS ubiquitylation. To understand how IpaH1.4 recognizes RNF213, we determined the cryogenic electron microscopy structure of the IpaH1.4-RNF213 complex. The specificity of the interaction is achieved through the leucine-rich repeat of IpaH1.4, which binds the RING domain of RNF213 by hijacking the conserved RING interface required for binding to ubiquitin-charged E2 enzymes. IpaH1.4 also targets other E3 ligases involved in inflammation and immunity through binding to the E2-interacting face of their RING domains, including the E3 ligase LUBAC that is required for the synthesis of M1-linked ubiquitin chains on cytosol-invading bacteria downstream of RNF213. We conclude that IpaH1.4 has evolved to antagonize multiple antibacterial and proinflammatory host E3 ligases.

Nature Structural & Molecular BiologyVol. 32(9)
MRC Laboratory of Molecular Biology (GB), Southwestern Medical Center (US), Origin Sciences (United Kingdom) (GB), AstraZeneca (Singapore) (SG), Addenbrooke's Hospital (GB), The University of Texas Southwestern Medical Center (US)
National Science Foundation, Wellcome Trust, Deutsche Forschungsgemeinschaft, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, National Institutes of Health, Directorate for Biological Sciences, Medical Research Council
Openalex Percentile: Top 2%
Autophagy in Disease and Therapy
9.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.